Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Metastatic Pancreatic Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. GOOGL
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Metastatic Pancreatic Cancer
(NASDAQ: NVCR) Delayed: 13.61 -0.67 (4.69%)
Previous Close $14.28    52 Week High $28.95 
Open $14.33    52 Week Low $5.95 
Day High $14.51    P/E N/A 
Day Low $13.51    EPS $0.00 
Volume 1,956,602